SPR Therapeutics Announces FDA Clearance of an Expanded Indication for the SPRINT® PNS System
SPR Therapeutics® has obtained clearance from the U.S. Food and Drug Administration (FDA) of a broader indication for use for its SPRINT...
top of page
Our Recent Posts
Archive
Follow us:
Email us:
Mutual Capital Partners
1290 Bassett Rd Suite #7
Westlake, OH 44145
©2024 by Mutual Capital Partners
bottom of page